Tecovirimat, sold under the brand name TPOXX and SIGA-246, is an antiviral medication with activity against orthopoxviruses such as smallpox and monkeypox. It is an inhibitor of the orthopoxvirus VP37 envelope wrapping protein and is indicated for the treatment of human smallpox disease in adults. It is the first antipoxviral drug approved in the United States. It is also used to treat complications that can happen following vaccination against smallpox.
See also Brincidofovir and Cidofovir
Cancer Research and Antivirals
|Appearance||White to off-white powder|
|Storage Conditions||-18 deg C|
|MDL Number||Request if not shown|
Send us your enquiry for Tecovirimat. We offer custom pack sizes at special prices. We aim to respond to your enquiry within 24 hours.
We value your input so if you have suggestions regarding new applications for Tecovirimat email us and we will include your contribution on the website.